OPN1SW and diabetic cardiomyopathy: These results agree with the reported cardiac protective effect of BCP in other cardiac models, including doxorubicin-induced acute cardiac injury [18], isoproterenol induced myocardial infraction [15,16], and diabetic cardiomyopathy [47].